<DOC>
	<DOCNO>NCT01733654</DOCNO>
	<brief_summary>The purpose study explore efficacy 6 week treatment investigational medication , RO4995819 , versus placebo adjunctive therapy patient major depression .</brief_summary>
	<brief_title>Investigate Efficacy &amp; Safety RO4995819 v . Placebo Adjunct Tx Patients w/Major Depressive Disorder</brief_title>
	<detailed_description>The investigator hope learn efficacy 6 week treatment RO4995819 versus placebo adjunctive therapy patient MDD inadequate response ongoing antidepressant treatment base mean change Montgomery Asberg Depression Rating Scale ( MADRS ) score baseline end treatment . This knowledge valuable new medication , may utility population patient major depressive disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Patients eligible enrollment study meet follow criterion : 1 . An outpatient w/a primary diagnosis major depressive disorder w/out psychotic feature 2 . Inadequate response current , ongoing antidepressant tx SSRI/SNRI . 3 . Having least 1 2 antidepressant treatment failure w/in index depressive episode 4 . Dose/duration antidepressant treatment index episode verify documentation one following : 1 . Med record ; 2 . Pharmacy record ; 3 . Treating and/or refer physician ( indicate medication , dose , date treatment ) . 5 . Documentation clinical/treatment history must available . 6 . Index depressive episode start w/in 1 year screening . 7 . Confirmed compliance w/current SSRI/SNRI treatment base blood screen . 8 . Existing med regimen stable 6 wks prior screen 9 . 1865 y.o . time consent 10 . BMI 18.0 35.0 kg/m2 inc. 11 . Patients w/reproductive potential must agree use specify contraceptive protection tx period least 90 day last dose study drug : Males w/partners childbearing potential partner must use barrier method contraception remain sexually abstinent . Females either surgically sterile ( tubal ligation , removal ovary uterus ) postmenopausal ( spontaneous menstrual period least 1 yr confirm hormone panel [ FSH 17βestradiol ] ) must agree use 2 adequate method contraception , include least one method w/ failure rate &lt; 1 % per yr ( e.g. , hormonal implant , combine oral contraceptive , vasectomized partner , abstinence ) . 12 . Able participate willing give write informed consent . Patients exclude study answer 'yes ' following : Current past treatment history : 1 . Currently receive tx w/3 antidepressant . 2 . Currently receive tx w/prohibited med . 3 . Significant ongoing use high dos barbiturate , benzodiazepine anxiolytic drug . 4 . Previously receive RO4995819 . 5 . Participated investigational drug device study w/in 6 mo screen index depressive episode . 6 . History nonresponse Electroconvulsive Therapy ( ECT ) , Vagus Nerve Stimulation ( VNS ) , Repetitive Transcranial Magnetic Stimulation ( RTMS ) . 7 . Planning begin/change current regimen individual psychotherapy include cognitive behavioral therapy 6 week treatment period study first 2 week followup . 8 . Present DSMIVTR axis I diagnosis except anxiety comorbidity 9 . Past present psychotic symptom . 10 . Mood disorder due medical condition substance use/abuse/dependence . 11 . Established personality disorder 12 . Alcohol and/or substance abuse/dependence last 6 month . 13 . A significant risk suicidal behavior 14 . Past present neurological disorder . 15 . Present eat disorder 16 . Abnormal thyroid function . 17 . Active upper gastrointestinal tract disease 18 . Unstable medical condition could pose unacceptable risk patient study . 19 . Positive result hepatitis B ( HBV ) , hepatitis C ( HCV ) , HIV 1 2 . 20 . Positive test drug abuse . 21 . Abnormality 12lead electrocardiogram ( ECG ) , include QTcF ≥450 milliseconds . 22 . Lab abnormality 23 . Positive pregnancy test , breast feeding , intention become pregnant course trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>depression</keyword>
	<keyword>major depressive disorder</keyword>
</DOC>